Skip to content

UBT251

Also called Vistrutide — GLP-1 / GIP / glucagon triple agonist

A triple agonist at the GLP-1, GIP and glucagon receptors.

  • TypePeptide
  • FormInjectable
  • Researched forMetabolic & Fat Loss

Where to get UBT251

Disguised Alpha
Injectable
Code CAMERON

21+ to enter. The only form sold. Research compound, not approved for human use.

Shop injectable at Disguised Alpha

The short version

  • Why people research itFat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
  • What the evidence isEarly clinical only.
  • What to watchBelly pain that spreads to the back.

How UBT251 works

A triple agonist at the GLP-1, GIP and glucagon receptors — the same three-receptor design as retatrutide. The glucagon arm is what separates the triples from the duals: glucagon raises energy expenditure directly rather than only suppressing intake, which is the mechanism the class is betting on for larger weight loss.

Three receptors, and the useful way to think about them is as three separate drugs sharing one syringe. UBT251 is described by its originator as a GLP-1 / GIP / glucagon triple receptor agonist.

The glucagon arm is the one that makes a triple different from a dual, and it is the one that cuts both ways. Glucagon-receptor agonism raises hepatic fat oxidation and whole-body energy expenditure — that is where weight loss beyond a GLP-1's comes from. It also raises hepatic glucose output, which is the opposite of what a diabetes drug wants, and it raises heart rate.

  • Injectable

On the goal map: Appetite & satiety signaling (Lose fat)

Research on UBT2515 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Human (early clinical, United Biotechnology; rights licensed to Novo Nordisk in 2026).

Human clinical evidence

  • Early clinical only. A GLP-1 / GIP / glucagon triple agonist from United Biotechnology, with rights licensed to Novo Nordisk in 2026. No phase 3 data.

  • A licensing deal is a commercial signal, not a clinical one. It says a large company liked the early data enough to pay for it. None of which is public.

Correlative data

  • Retatrutide is the closest read: same three receptors, same design logic, and considerably further along. The class-wide pattern so far is that the glucagon arm buys additional weight loss and additional gastrointestinal burden.

How the mechanism reads

  • The glucagon arm is what separates a triple from a dual. GLP-1 and GIP act mostly on intake and insulin handling; glucagon raises energy expenditure directly. That is the bet the whole triple-agonist class is making.

    Mechanistic
  • Like everything in this class — it goes in its own syringe.

    Mechanistic

Sources

UBT251 safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Medullary thyroid cancer in you or family, or MEN2.
  • Pancreatitis history or gallbladder disease.
  • Insulin or sulfonylurea use, since three arms lower glucose.
  • Resting rapid pulse: the glucagon arm lifts heart rate.
  • Wanting solid human data: only early clinical work exists.

What’s expected

  • If it behaves like other triples: large appetite fall plus glucagon-driven energy burn.
  • Nausea early.
  • Raised heart rate.
  • Fat and lean mass both fall.

Watch for

  • Belly pain that spreads to the back.
  • Pounding heart at rest.
  • Yellow eyes while using UBT251.
  • Dehydration from vomiting.

Labs that tell you it’s working

  • Lipase
  • HbA1c (Hemoglobin A1c)
  • Lipid Panel
  • Comprehensive Metabolic Panel (CMP)

UBT251 (vistrutide) is a GLP-1, GIP and glucagon triple agonist in early trials; thinner data reflect timing, not failure.

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

A panel picked from how it works and what it can move: the tests, and why each is on it.

9 tests in one order
Marek Diagnostics · no doctor’s visit
Code CAMERON
Order this panel

Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.

The Metabolic Health & Prediabetes panel, explained

UBT251 FAQ4 common questions

Is UBT251 approved for human use?
No. UBT251 is a research compound.
What is UBT251 researched for?
Fat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
Which labs show whether it's doing anything?
Lipase; HbA1c; Lipid Panel; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for UBT251: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what UBT251 is. Skool covers how it is run.

Free on this page

What UBT251 is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What UBT251 is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool